Head and Neck Cancers Coverage from Every Angle
Advertisement
Advertisement

Glenn Hanna, MD, on Using Checkpoint Inhibitors for Head and Neck Cancer

Posted: Thursday, May 24, 2018

Glenn Hanna, MD, of Dana-Farber Cancer Institute, discusses the most common clinical issues seen in patients treated with an immune checkpoint inhibitor and how to best manage the side effects.

Advertisement
Advertisement


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.